Model
Edge
Janux Therapeutics
0001864159
Filing Type
4
Filing Date
12/2/2025
Updated
12/3/25, 6:00 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership